Luca Quagliata is currently serving as Vice-President and Global Head of Medical and Scientific Affairs at Thermo Fisher Scientific. This division is a key strategic part of Thermo Fisher's business, dedicated to advancing Precision Oncology through its cutting-edge solutions for research and clinical applications. In his current role, Luca leads an international team of Medical and Scientific Affairs experts and is responsible for managing, preserving, and enhancing key strategic partnerships with major healthcare providers, academic centers, pharmaceutical companies, and institutional organizations that play a pivotal role in the fields of Oncology and Pathology on a global level. 

Luca is also an adjunct faculty member in the International Master in Innovative Medicine at the Faculty of Medicine, University of Heidelberg, Germany, and serves as a Venture Partner at xGen Venture SGR. Previously, he worked at University Hospital Basel in Switzerland, namely at the Institute of Medical Genetics and Pathology, holding various positions including Senior Director of the R&D Unit and Leader of the Molecular Diagnostics Team. 

Luca holds a Ph.D. in Vascular Medicine from the Mannheim Faculty of Medicine, University of Heidelberg, Germany, and is a Board-Certified Medical Affairs Specialist (BCMAS).